← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2007Last known activity
Oct 1, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT04536363Lead sponsorPhase 2Oct 1, 2020
- NCT04536363Sponsor investigatorPhase 2Oct 1, 2020
- NCT04425837Reponsible party - principal investigatorPhase 2/Phase 3Jul 31, 2020
- NCT04425837Lead sponsorPhase 2/Phase 3Jul 31, 2020
- NCT02599077Lead sponsorPhase 2/Phase 3Nov 1, 2015
- NCT02599077Reponsible party - principal investigatorPhase 2/Phase 3Nov 1, 2015
- NCT02599077Study chairPhase 2/Phase 3Nov 1, 2015
- NCT02510287Lead sponsorN/AJul 1, 2015
- NCT02510287Reponsible party - principal investigatorN/AJul 1, 2015
- NCT01347450Lead sponsorN/AOct 1, 2007
Details
- Last known activity
- Oct 1, 2020